A phase Ib study of combination Regorafenib with PF-03446962 in patient with refactory metastatic colorectal cancer or GIST.
Clinical Trial Grant
Awarded By
Pfizer, Inc.
Start Date
January 1, 2013
End Date
September 30, 2019
Awarded By
Pfizer, Inc.
Start Date
January 1, 2013
End Date
September 30, 2019